|3Feb 18, 5:07 PM ET

Weiss Asset Management LP 3

3 · AVADEL PHARMACEUTICALS PLC · Filed Feb 18, 2026

Insider Transaction Report

Form 3
Period: 2026-02-11
Holdings
  • Ordinary Shares

    [F1]
    (indirect: See Footnote 1)
    11,112,052
Footnotes (1)
  • [F1]Shares reported herein represent shares beneficially owned by two private investment funds for which Weiss Asset Management LP serves as investment manager. WAM GP LLC is the general partner of Weiss Asset Management LP and Andrew Weiss is the Manager of WAM GP LLC. All of Weiss Asset Management LP, WAM GP LLC, and Andrew Weiss disclaim beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein.

Documents

1 file
  • 3
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT